rs6439886 — CLSTN2

Intronic variant in the calsyntenin-2 gene associated with episodic memory performance and hippocampal inhibitory circuit function

See your personal result for CLSTN2

Upload your DNA data to find out which genotype you carry and what it means for you.

Upload your DNA data

Works with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.

CLSTN2 — The Synaptic Scaffold Behind Memory Precision

In 2006, the first genome-wide association study of episodic memory in healthy adults identified two genes linked to how well people remember verbal information. The first, KIBRA, became famous. The second, CLSTN211 CLSTN2
Calsyntenin-2 (calsyntenin 2), a postsynaptic transmembrane protein of the cadherin superfamily expressed exclusively in brain tissue, received less attention — but has since accumulated its own evidence base connecting it to memory circuits, inhibitory neuron integrity, and the hippocampus22 hippocampus
The seahorse-shaped brain structure critical for forming and retrieving episodic memories — the kind tied to specific events and experiences.

The Mechanism

CLSTN2 encodes a 955-amino-acid protein with two cadherin repeats33 cadherin repeats
Structural domains that mediate calcium-dependent cell-cell adhesion; in neurons they help organize the postsynaptic density at synaptic junctions, a transmembrane domain, and a cytoplasmic tail. It is expressed exclusively in neural tissue, concentrated in the postsynaptic specializations of excitatory synapses — particularly in layers 5 and 6 of the cerebral cortex and throughout the hippocampus. Despite its location at excitatory synapses, calsyntenin-2 appears to exert its primary cognitive influence through a different circuit: it is required for the maintenance of inhibitory interneurons.

Mouse knockout studies44 Mouse knockout studies
Lipina TV et al. Cognitive Deficits in Calsyntenin-2-deficient Mice Associated with Reduced GABAergic Transmission. Neuropsychopharmacology, 2016 showed that complete loss of CLSTN2 reduced the density of parvalbumin-positive GABAergic interneurons55 parvalbumin-positive GABAergic interneurons
Fast-spiking inhibitory neurons that generate gamma-frequency oscillations (30-80 Hz) essential for encoding and retrieving episodic memories; they coordinate excitatory pyramidal cell firing with millisecond precision in hippocampal CA1, CA3, and dentate gyrus by 25-56%, with no effect on other interneuron subtypes (somatostatin, calretinin, calbindin). The result was a selective reduction in inhibitory postsynaptic currents and impaired spatial memory on the Morris water maze — while excitatory transmission and non-spatial cognition remained intact. The SNP rs6439886 sits in the first intron and does not alter the protein sequence directly; it is presumed to influence CLSTN2 expression in hippocampal tissue, though the exact regulatory mechanism has not been fully characterized.

The Evidence

The original GWAS66 original GWAS
Papassotiropoulos A et al. Common Kibra alleles are associated with human memory performance. Science, 2006 screened over 500,000 SNPs in 351 young Swiss adults and identified rs6439886 as one of two loci associated with the best verbal episodic memory performers (the other being KIBRA rs17070145). Carriers of the G allele — described as the C allele in coding-strand notation — outperformed AA homozygotes on delayed free recall. Unlike the KIBRA finding, the CLSTN2 association was not replicated in the American cohort within the same study, suggesting possible population differences or age-dependence.

Subsequent independent studies have supported and extended the finding. A study in 383 healthy young adults77 study in 383 healthy young adults
Preuschhof C et al. KIBRA and CLSTN2 polymorphisms exert interactive effects on human episodic memory. Neuropsychologia, 2010 found that CLSTN2 and KIBRA genotypes interact: the G allele of CLSTN2 positively modulates memory performance in people who also carry the KIBRA T allele. In KIBRA CC homozygotes, the CLSTN2 G allele provided no benefit or was slightly detrimental, suggesting the two genes converge on shared synaptic plasticity pathways.

In adolescents, a neuroimaging study88 neuroimaging study
Jacobsen LK et al. Allelic variation of calsyntenin 2 (CLSTN2) modulates the impact of developmental tobacco smoke exposure on mnemonic processing in adolescents. Biological Psychiatry, 2009 confirmed a beneficial effect of the G allele on verbal recall and showed that this advantage is associated with enhanced functional connectivity between memory-related brain regions. Crucially, developmental tobacco smoke exposure eliminated the memory benefit and reversed the connectivity advantage in G carriers — making this one of the first demonstrations that a genetic memory advantage can be cancelled by environmental exposure during a sensitive developmental period.

In older adults with unipolar depression, a study of 2,170 people aged 60+99 a study of 2,170 people aged 60+
Pantzar A et al. Interactive effects of KIBRA and CLSTN2 polymorphisms on episodic memory in old-age unipolar depression. Neuropsychologia, 2014 found that the combination of KIBRA CC and CLSTN2 AA genotypes was specifically associated with the lowest episodic memory performance among depressed individuals. Genetic effects on cognition appear to be amplified in populations with suboptimal cognitive reserve. A polygenic analysis of 2,490 dementia-free older adults1010 polygenic analysis of 2,490 dementia-free older adults
Laukka EJ et al. Combined genetic influences on episodic memory decline in older adults without dementia. Neuropsychology, 2020 found that a composite score including APOE, BDNF, KIBRA, and CLSTN2 risk alleles predicted faster episodic memory decline (β=-0.064, p<0.01), though CLSTN2 alone was not significant in that cohort.

Practical Implications

The actionable picture for AA homozygotes — the most common genotype — is one of modest increased vulnerability to episodic memory decline over time, particularly in conjunction with other memory-related variants and in the presence of environmental stressors. The CLSTN2 mechanism points specifically toward GABAergic interneuron health and synaptic inhibitory-excitatory balance in the hippocampus. Strategies that support parvalbumin interneuron function, promote hippocampal neuroplasticity, and protect against age-related inhibitory circuit loss are the most mechanistically coherent interventions.

Phosphatidylserine is one of the few supplements with reasonable clinical trial evidence for verbal memory support in older adults, with double-blind placebo-controlled data showing improvement in delayed verbal recall in people with subjective memory complaints. Its mechanism — supporting neuronal membrane integrity and signaling — is complementary to CLSTN2's role in maintaining synaptic scaffolding.

Importantly, the tobacco smoke reversal of the G allele memory benefit is a reminder that genetic advantages are not immune to environmental damage, particularly during development.

Interactions

The interaction between CLSTN2 rs6439886 and KIBRA rs17070145 is well documented. The memory-enhancing effect of the CLSTN2 G allele is contingent on the KIBRA T allele being present; in KIBRA CC homozygotes, CLSTN2 G provides no benefit and may be mildly detrimental. Both proteins operate in hippocampal synaptic plasticity pathways — KIBRA through PKMzeta-mediated long-term potentiation, CLSTN2 through maintenance of parvalbumin interneuron density. The combination of KIBRA CC and CLSTN2 AA (both risk-direction genotypes) is associated with the lowest episodic memory performance in studies of older adults with depression. This interaction is a candidate for a compound action: individuals carrying both KIBRA CC and CLSTN2 AA genotypes face additive risk and may benefit from more aggressive memory-supportive strategies than either variant alone would suggest.

Genotype Interpretations

What each possible genotype means for this variant.

AA Standard Memory Profile Normal

Common genotype with average episodic memory baseline

The AA genotype at rs6439886 is the most common configuration globally, with the A allele present at approximately 87% frequency in European populations and 82-91% across major ancestry groups. In the original 2006 GWAS, AA homozygotes were in the reference group against which G-allele carriers were compared in the Swiss cohort. The association between this variant and memory failed to replicate in the American cohort of the same study, suggesting the effect may be modest, population- specific, or age-dependent.

The CLSTN2 mechanism is relevant to long-term hippocampal health: mouse models show that loss of CLSTN2 function reduces parvalbumin-positive GABAergic interneurons by 25-56% in the hippocampus. While the human intronic variant has a much subtler effect than complete gene deletion, it points toward inhibitory circuit integrity as the relevant biological pathway. The polygenic study by Laukka et al. (2020) suggests that the AA genotype contributes modestly to memory decline risk when combined with risk alleles at APOE, BDNF, and KIBRA.

For AA homozygotes, the most meaningful intervention is ensuring that co-occurring risk factors — other memory-related genotypes, cardiovascular risk factors, depression, and inflammatory burden — are managed proactively.

AG Partial Memory Advantage Beneficial

One copy of the memory-associated G allele

Heterozygous AG individuals carry one G allele, the less common variant associated with better verbal memory in the original Papassotiropoulos et al. (2006) Science study and replicated in adolescents and older adults. The 2010 Preuschhof et al. study in 383 healthy young adults showed that the CLSTN2 G allele boosted the memory benefits of the KIBRA T allele, with the combined effect largest on complex associative memory tasks. In the AG genotype, one copy of CLSTN2 produces the G-variant protein, which may support modestly better hippocampal parvalbumin interneuron density compared to AA, though heterozygous effects have not been directly measured in human neuroimaging studies.

The adolescent tobacco smoke study by Jacobsen et al. (2009) is worth noting: among G-allele carriers, developmental tobacco smoke exposure reversed the memory advantage and disrupted functional connectivity between memory-relevant brain regions. This makes this variant one of the few memory-related SNPs where a documented environmental exposure can eliminate the genetic benefit.

GG Strongest Memory Profile Beneficial

Two copies of the memory-associated G allele

GG homozygotes represent the minor-allele homozygous state for rs6439886, with a global frequency of approximately 1-2% and somewhat higher in African-ancestry populations (~3%). Two copies of the G allele would be expected to maximize CLSTN2 expression in hippocampal tissue, supporting parvalbumin interneuron density and inhibitory-excitatory balance throughout the hippocampus and temporal cortex.

The rarity of this genotype means it has rarely been analyzed separately from heterozygous AG carriers in published studies — most studies combine AG and GG into a "G-carrier" group. The effect observed in G carriers overall — better verbal recall, enhanced parahippocampal connectivity during memory tasks, and protection against the KIBRA CC memory deficit — should apply at least as strongly to GG homozygotes, though direct evidence specifically in GG individuals is limited due to small sample sizes.

Even with the GG genotype, developmental tobacco smoke exposure eliminates the memory advantage (per the Jacobsen et al. 2009 study), underscoring that the genetic benefit requires an intact hippocampal environment to manifest.